Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide‐co‐glycolide) sintered microsphere scaffolds for bone tissue engineering
暂无分享,去创建一个
Cato T Laurencin | Lakshmi S Nair | C. Laurencin | T. Jiang | M. Deng | L. Nair | Tao Jiang | Meng Deng | Ehsan Jabbarzadeh | Y. Khan | Yusuf M Khan | E. Jabbarzadeh
[1] R. Langer,et al. Degradation of Poly(Anhydride-Co-Imides): Novel Polymers for Orthopedic Applications , 1995 .
[2] R. Ian Freshney,et al. Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications , 2010 .
[3] Kenneth M. Yamada,et al. Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.
[4] Yasuhiko Tabata,et al. Effect of the fiber diameter and porosity of non-woven PET fabrics on the osteogenic differentiation of mesenchymal stem cells , 2004, Journal of biomaterials science. Polymer edition.
[5] C T Laurencin,et al. Tissue-engineered bone formation in vivo using a novel sintered polymeric microsphere matrix. , 2004, The Journal of bone and joint surgery. British volume.
[6] Cato T Laurencin,et al. The sintered microsphere matrix for bone tissue engineering: in vitro osteoconductivity studies. , 2002, Journal of biomedical materials research.
[7] J. Vacanti,et al. Tissue engineering : Frontiers in biotechnology , 1993 .
[8] C. Laurencin,et al. Schwannoma of the superficial peroneal nerve presenting as web space pain. , 1995, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.
[9] S. Weiss,et al. Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.
[10] H. Othmer,et al. Mathematical modeling of tumor-induced angiogenesis , 2004, Journal of mathematical biology.
[11] Cato T Laurencin,et al. In vitro bone formation using muscle-derived cells: a new paradigm for bone tissue engineering using polymer-bone morphogenetic protein matrices. , 2003, Biochemical and biophysical research communications.
[12] Cato T. Laurencin,et al. Fiber Based Tissue Engineered Scaffolds for Musculoskeletal Applications: in Vitro Cellular Response , 1998 .
[13] C. Laurencin,et al. Structural and human cellular assessment of a novel microsphere-based tissue engineered scaffold for bone repair. , 2003, Biomaterials.
[14] David J. Mooney,et al. Increased Vascularization and Heterogeneity of Vascular Structures Occurring in Polyglycolide Matrices Containing Aortic Endothelial Cells Implanted in the Rat , 1997 .
[15] D J Mooney,et al. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[16] C. Laurencin,et al. Expression of IL-1 genes in human and bovine chondrocytes: a mechanism for autocrine control of cartilage matrix degradation. , 1986, Biochemical and biophysical research communications.
[17] Joyce Bischoff,et al. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. , 2004, American journal of physiology. Heart and circulatory physiology.
[18] L. Hanley,et al. Preparation and analysis of macroporous TiO2 films on Ti surfaces for bone-tissue implants. , 2001, Journal of biomedical materials research.
[19] W M Reichert,et al. Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. , 1998, Journal of biomedical materials research.
[20] Cato T Laurencin,et al. Tissue engineered microsphere-based matrices for bone repair: design and evaluation. , 2002, Biomaterials.
[21] Stuart K Williams,et al. Angiogenesis and neovascularization associated with extracellular matrix-modified porous implants. , 2002, Journal of biomedical materials research.
[22] Cato T Laurencin,et al. In vitro evaluation of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds for bone tissue engineering. , 2006, Biomaterials.
[23] J. Tomasek,et al. Mechanical properties of the extracellular matrix influence fibronectin fibril assembly in vitro. , 1995, Experimental cell research.
[24] B. Ratner. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[25] Jeffrey O. Hollinger,et al. Biomedical applications of synthetic biodegradable polymers , 1995 .
[26] J. Folkman. The vascularization of tumors. , 1976, Scientific American.
[27] J. A. Cooper,et al. Tissue engineering: orthopedic applications. , 1999, Annual review of biomedical engineering.
[28] David J Mooney,et al. VEGF Scaffolds Enhance Angiogenesis and Bone Regeneration in Irradiated Osseous Defects , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[29] N. Ilan,et al. PECAM-1: old friend, new partners. , 2003, Current opinion in cell biology.
[30] A. Perets,et al. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. , 2003, Journal of biomedical materials research. Part A.
[31] H. DeLisser,et al. Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. , 2002, American journal of physiology. Cell physiology.
[32] H R Allcock,et al. Novel polyphosphazene/poly(lactide-co-glycolide) blends: miscibility and degradation studies. , 1997, Biomaterials.
[33] R. Langer,et al. Designing materials for biology and medicine , 2004, Nature.
[34] P. J. Newman,et al. The biology of PECAM-1. , 1997, The Journal of clinical investigation.
[35] A. Mikos,et al. Angiogenesis with biomaterial-based drug- and cell-delivery systems , 2004, Journal of biomaterials science. Polymer edition.
[36] C T Laurencin,et al. Tissue engineered bone-regeneration using degradable polymers: the formation of mineralized matrices. , 1996, Bone.
[37] C. Colton,et al. Implantable biohybrid artificial organs. , 1995, Cell transplantation.
[38] R. Nadeau,et al. Liberation of cyclic AMP and catecholamine from the heart during left stellate stimulation in the anesthetized dog. , 1981, Canadian journal of physiology and pharmacology.
[39] A. U. Daniels,et al. Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. , 2005, Biomaterials.
[40] C. Garlanda,et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis. , 1997, The American journal of pathology.
[41] C T Laurencin,et al. Osteoblast-like cell adherance and migration through 3-dimensional porous polymer matrices. , 1995, Biochemical and biophysical research communications.
[42] Antonios G. Mikos,et al. Pore Morphology Effects on the Fibrovascular Tissue Growth in Porous Polymer Substrates , 1994, Cell transplantation.
[43] Robert Langer,et al. Synthesis and Characterization of Degradable Poly(anhydride-co-imides) , 1995 .
[44] S. Zigmond,et al. Signal transduction and actin filament organization. , 1996, Current opinion in cell biology.
[45] D. Jackson. The unfolding tale of PECAM‐1 , 2003, FEBS letters.
[46] Amit Bandyopadhyay,et al. Pore size and pore volume effects on alumina and TCP ceramic scaffolds , 2003 .
[47] K. Burg,et al. Biomaterial developments for bone tissue engineering. , 2000, Biomaterials.
[48] Y. Ikada,et al. Vascularization into a porous sponge by sustained release of basic fibroblast growth factor. , 1999, Journal of biomaterials science. Polymer edition.
[49] D. Katti,et al. Regional drug delivery with radiation for the treatment of Ewing's sarcoma. In vitro development of a taxol release system. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[50] D. Bullard,et al. Intercellular Adhesion Molecule-1 (ICAM-1) Regulates Endothelial Cell Motility through a Nitric Oxide-dependent Pathway* , 2004, Journal of Biological Chemistry.
[51] David J. Mooney,et al. Promoting Angiogenesis in Engineered Tissues , 2001, Journal of drug targeting.
[52] C T Laurencin,et al. Toxicity, biodegradation and elimination of polyanhydrides. , 2002, Advanced drug delivery reviews.
[53] C. Laurencin,et al. Polymeric controlled release systems: new methods for drug delivery. , 1987, Clinics in laboratory medicine.
[54] David J Mooney,et al. Engineering vascular networks in porous polymer matrices. , 2002, Journal of biomedical materials research.
[55] C. Laurencin,et al. Cell-material systems for anterior cruciate ligament regeneration , 1998, In Vitro Cellular & Developmental Biology - Animal.